[ad_1]
- “CUVIS-spine” can be used in all countries/regions by obtaining licenses from FDA (United States), South Korea and the United States. Europe.
- “CUVIS-spine” can reduce the operation time of minimally invasive surgery (MIS).
Seoul, Korea, May 21, 2021 / PRNewswire / On the 20th, CUREXO Corp. (060280), a medical robotics specialist company, announced their independently developed spinal surgery Robot’CUVIS-spine’ has been approved by the FDA (USA).
The FDA (US) license, followed by South Korea (2019) and the European CE (2020) certificate, is the third license they have obtained, and their products are now available to all countries/regions.
Currently, two “CUVIS-spines” are used in Severance Hospital (South Korea), and one of them has been exported to a medical institution in Australia. CUREXO also plans to expand its focus on global markets including the United States and the United States. Europe.
The spine surgery robot “CUVIS-spine” is a next-generation spine surgery robot that can guide the insertion of pedicle screws according to the surgical plan. Compared with traditional manual surgery, it uses high-precision robotic arms, wireless single-step navigation and navigation based on real-time GPS sensors, which can provide precise, safe and fast surgery. Moreover, it minimizes film formation and reduces the radiation exposure of patients and medical staff.
This solution can use 2D film (C-arm) and 3D film (O-arm) at the same time, and has great scalability. With the help of wireless single-step and robotic system, it can use one surgical tool to perform multiple steps (needle, K-line, expansion, percussion) of traditional manual surgery, and greatly reduce the operation time. It allows for minimally invasive surgery (MIS), which means that patients have faster recovery time compared to manual surgery.
Mr Lee Jae Joon (CEO of CUREXO) said:This The spine surgery robot “CUVIS-spine” that we developed and manufactured using our technology has been approved by the FDA (United States).This is the third license we have obtained, followed by South Korea and Europe, And now we can sell our solutions in all countries, including the largest medical market, the United States. “He also said: “CUREXO plans to focus on our medical robot sales, including’CUVIS-joint’,’CUVIS-spine’ and “Morning Walk” not only for the Korean market, but also for the United States and the United States and other advanced Medical market Europe. ”
Media contact:
Li Xiang
hylee@curexo.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/curexos-spinal-surgery-robot-cuvis-spine-acquired-fda-us-licensing-301297120.html
Source CUREXO
[ad_2]
Source link
